The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Phillip J. Mease

Correspondence to Philip J Mease

Department of Rheumatology

Seattle Rheumatology Associates

1101 Madison Street Ste 1000



Name/email consistency: high



  • Correspondence to Philip J Mease, Department of Rheumatology, Seattle Rheumatology Associates, 1101 Madison Street Ste 1000, USA;. 2012
  • Seattle Rheumatology Associates, 1101 Madison Street, Suite 1000, Seattle. 2010 - 2012
  • University of Washington, Seattle, USA. 2011
  • Seattle Rheumatology Associates, Rheumatology Clinical Research, Swedish Medical Center, University of Washington School of Medicine, USA. 2003 - 2010
  • Swedish Medical Center and University of Washington, Seattle, Washington, USA. 2005 - 2009
  • Division of Rheumatology Research, Swedish Medical Center. 2006


  1. A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate. Mease, P., Strand, V., Shalamberidze, L., Dimic, A., Raskina, T., Xu, L.A., Liu, Y., Smith, J. Ann. Rheum. Dis. (2012) [Pubmed]
  2. Distinguishing Inflammatory from Noninflammatory Arthritis, Enthesitis, and Dactylitis in Psoriatic Arthritis: A Report from the GRAPPA 2010 Annual Meeting. Mease, P.J. J. Rheumatol. (2012) [Pubmed]
  3. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. Mease, P.J., Hanna, S., Frakes, E.P., Altman, R.D. J. Rheumatol. (2011) [Pubmed]
  4. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Mease, P., Genovese, M.C., Gladstein, G., Kivitz, A.J., Ritchlin, C., Tak, P.P., Wollenhaupt, J., Bahary, O., Becker, J.C., Kelly, S., Sigal, L., Teng, J., Gladman, D. Arthritis Rheum. (2011) [Pubmed]
  5. Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial. Mease, P.J., Cohen, S., Gaylis, N.B., Chubick, A., Kaell, A.T., Greenwald, M., Agarwal, S., Yin, M., Kelman, A. J. Rheumatol. (2010) [Pubmed]
  6. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. Mease, P.J., Woolley, J.M., Singh, A., Tsuji, W., Dunn, M., Chiou, C.F. J. Rheumatol. (2010) [Pubmed]
  7. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study. Mease, P.J., Wei, N., Fudman, E.J., Kivitz, A.J., Schechtman, J., Trapp, R.G., Hobbs, K.F., Greenwald, M., Hou, A., Bookbinder, S.A., Graham, G.E., Wiesenhutter, C.W., Willis, L., Ruderman, E.M., Forstot, J.Z., Maricic, M.J., Dao, K.H., Pritchard, C.H., Fiske, D.N., Burch, F.X., Prupas, H.M., Anklesaria, P., Heald, A.E. J. Rheumatol. (2010) [Pubmed]
  8. Assessing the impact of psoriatic arthritis on patient function and quality of life: lessons learned from other rheumatologic conditions. Mease, P.J. Semin. Arthritis Rheum. (2009) [Pubmed]
  9. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Mease, P.J., Ory, P., Sharp, J.T., Ritchlin, C.T., Van den Bosch, F., Wellborne, F., Birbara, C., Thomson, G.T., Perdok, R.J., Medich, J., Wong, R.L., Gladman, D.D. Ann. Rheum. Dis. (2009) [Pubmed]
  10. Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study. Mease, P.J., Reich, K. J. Am. Acad. Dermatol. (2009) [Pubmed]
  11. Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. Mease, P.J. Am. J. Med. (2009) [Pubmed]
  12. Psoriatic arthritis assessment and treatment update. Mease, P.J. Curr. Opin. Rheumatol (2009) [Pubmed]
  13. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application. Mease, P.J. J. Rheumatol. (2008) [Pubmed]
  14. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial. Mease, P.J., Revicki, D.A., Szechinski, J., Greenwald, M., Kivitz, A., Barile-Fabris, L., Kalsi, J., Eames, J., Leirisalo-Repo, M. J. Rheumatol. (2008) [Pubmed]
  15. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. Mease, P.J., Russell, I.J., Arnold, L.M., Florian, H., Young, J.P., Martin, S.A., Sharma, U. J. Rheumatol. (2008) [Pubmed]
  16. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Mease, P.J., Arnold, L.M., Crofford, L.J., Williams, D.A., Russell, I.J., Humphrey, L., Abetz, L., Martin, S.A. Arthritis Rheum. (2008) [Pubmed]
  17. Assessment tools in psoriatic arthritis. Mease, P.J. J. Rheumatol. (2008) [Pubmed]
  18. Spondyloarthritis update: new insights regarding classifcation, pathophysiology, and management. Mease, P.J. Bulletin. Nyu. Hospital. Joint. Diseases (2008) [Pubmed]
  19. Fibromyalgia syndrome. Mease, P., Arnold, L.M., Bennett, R., Boonen, A., Buskila, D., Carville, S., Chappell, A., Choy, E., Clauw, D., Dadabhoy, D., Gendreau, M., Goldenberg, D., Littlejohn, G., Martin, S., Perera, P., Russell, I.J., Simon, L., Spaeth, M., Williams, D., Crofford, L. J. Rheumatol. (2007) [Pubmed]
  20. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. Mease, P.J., Kivitz, A.J., Burch, F.X., Siegel, E.L., Cohen, S.B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J.T., Dunn, M., Tsuji, W. J. Rheumatol. (2006) [Pubmed]
  21. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. Mease, P.J., Menter, M.A. J. Am. Acad. Dermatol. (2006) [Pubmed]
  22. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Mease, P.J., Gladman, D.D., Keystone, E.C. Arthritis Rheum. (2006) [Pubmed]
  23. Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology. Mease, P. Curr. Rheumatol. Rep (2006) [Pubmed]
  24. Current treatment for psoriatic arthritis and other spondyloarthritides. Mease, P. Rheum. Dis. Clin. North Am. (2006) [Pubmed]
  25. Diagnosis and treatment of psoriatic arthritis. Mease, P., Goffe, B.S. J. Am. Acad. Dermatol. (2005) [Pubmed]
  26. Psoriatic arthritis assessment tools in clinical trials. Mease, P.J., Antoni, C.E., Gladman, D.D., Taylor, W.J. Ann. Rheum. Dis. (2005) [Pubmed]
  27. Psoriatic arthritis treatment: biological response modifiers. Mease, P.J., Antoni, C.E. Ann. Rheum. Dis. (2005) [Pubmed]
  28. Psoriatic arthritis therapy advances. Mease, P.J. Curr. Opin. Rheumatol (2005) [Pubmed]
  29. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. Mease, P. J. Rheumatol. Suppl (2005) [Pubmed]
  30. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Mease, P.J., Gladman, D.D., Ritchlin, C.T., Ruderman, E.M., Steinfeld, S.D., Choy, E.H., Sharp, J.T., Ory, P.A., Perdok, R.J., Weinberg, M.A. Arthritis Rheum. (2005) [Pubmed]
  31. Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis. Mease, P.J. Expert. Opin. Biol. Ther (2005) [Pubmed]
  32. Fibromyalgia syndrome. Mease, P.J., Clauw, D.J., Arnold, L.M., Goldenberg, D.L., Witter, J., Williams, D.A., Simon, L.S., Strand, C.V., Bramson, C., Martin, S., Wright, T.M., Littman, B., Wernicke, J.F., Gendreau, R.M., Crofford, L.J. J. Rheumatol. (2005) [Pubmed]
  33. TNFalpha therapy in psoriatic arthritis and psoriasis. Mease, P. Ann. Rheum. Dis. (2004) [Pubmed]
  34. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. Mease, P.J., Ritchlin, C.T., Martin, R.W., Gottlieb, A.B., Baumgartner, S.W., Burge, D.J., Whitmore, J.B. J. Rheumatol. (2004) [Pubmed]
  35. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Mease, P.J., Kivitz, A.J., Burch, F.X., Siegel, E.L., Cohen, S.B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J.T., Tsuji, W. Arthritis Rheum. (2004) [Pubmed]
  36. Disease-modifying antirheumatic drug therapy for spondyloarthropathies: advances in treatment. Mease, P.J. Curr. Opin. Rheumatol (2003) [Pubmed]
  37. Current treatment of psoriatic arthritis. Mease, P.J. Rheum. Dis. Clin. North Am. (2003) [Pubmed]
WikiGenes - Universities